Pharmaceutical

Odyssey bails on public listing as US IPO landscape stutters

Following a flurry of activity in early 2025, the IPO scene has cooled in the wake of President Trump’s economic tremors.

Jun 11, 2025 - 06:00
Odyssey bails on public listing as US IPO landscape stutters
Following a flurry of activity in early 2025, the IPO scene has cooled in the wake of President Trump’s economic tremors.
Read the original article

Tags:

Previous Article

Outlook’s wet AMD treatment accepted by SMC for NHS Scotland

Next Article

Mosanna Therapeutics gains $80m to advance OSA nasal spray

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Dana-Farber, in break with Brigham and Women’s, will build new cancer center with Beth Israel

STAT+: Dana-Farber, in break with Brigham and Women’s, ...

Sep 14, 2023

STAT+: Colorado pioneered legal marijuana without sparking ‘reefer madness,’ but challenges lie ahead

STAT+: Colorado pioneered legal marijuana without spark...

Oct 30, 2023

STAT+: Feds fine Medicare Advantage plans for overcharging their members

STAT+: Feds fine Medicare Advantage plans for overcharg...

Aug 29, 2023